T2J-24062-04396
4 vaccinations
3 coded responses
37 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 750 / TX
- Registered
- 2021-01-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
5JG-53449-11823
Child or adolescent in my care · Male · 2021-12-27
3ZE-95251-54807
Child or adolescent in my care · Female · 2021-12-27
42E-57699-47362
Child or adolescent in my care · Male · 2022-12-30
Timeline
-
2021-01-27
Registered in v-safe
-
2021-01-27
Dose 1 — Moderna
- 2021-01-27
-
2021-01-28
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fatigue or tirednessAdult check-in
-
2021-01-29
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-01-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
- 2021-01-31
- 2021-02-01
-
2021-02-02
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-02-03
- 2021-02-10
- 2021-02-19
- 2021-02-24
-
2021-03-01
Dose 2 — Moderna
-
2021-03-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to workAdult check-in
- 2021-03-04
-
2021-03-05
Survey response — days 1–6 daily, dose 2MedDRA: Constipation — Feeling: Good · Site: PainFree text: ConstipationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-06
- 2021-03-07
- 2021-03-09
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-05-31
-
2022-01-03
Dose 3 — Moderna
-
2022-01-04
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2022-01-05
- 2022-01-06
- 2022-01-07
- 2022-01-08
- 2022-01-09
-
2022-01-10
Survey response — day 7, dose 3MedDRA: Cough — Feeling: Fair · Fever · Be unable to work or attend schoolFree text: CoughMedDRA releases: 2024-11 · check-in free text available
-
2022-01-17
Survey response — day 14, dose 3MedDRA: Cough — Feeling: Fair · Be unable to work or attend schoolFree text: Dry CoughMedDRA releases: 2024-11 · check-in free text available
- 2022-01-26
- 2022-01-31
- 2022-02-07
- 2022-04-04
-
2022-12-30
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-12-30
- 2023-01-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-27 | Moderna | |
| 2 | 2021-03-01 | Moderna | |
| 3 | 2022-01-03 | Moderna | No |
| 4 | 2022-12-30 | Pfizer-BioNTech | Flu |
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Constipation
Release 10 — day 7, dose 3
Systemic reaction (other): Cough
Release 10 — day 14, dose 3
Symptoms: Dry Cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SRO | Constipation | ✓ | ✓ | ✓ |
| SRO | Cough | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release